A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

Scand J Rheumatol. 2004;33(3):140-4. doi: 10.1080/03009740310004892.

Abstract

Objective: To report a novel mutation of the TNF receptor type 1 gene (TNFRSF1A) in a Finnish patient and her mother, both suffering from periodic fever.

Methods: Soluble TNFRSF1A in serum was measured by enzyme-linked immunoabsorbancy, and induced TNFRSF1A shedding from monocyte cell surfaces was determined using fluorescence-activated cell sorter. Mutation detection was performed using PCR amplification and sequencing of the ten exons of TNFRSF1A.

Results: Low levels of soluble TNFRSF1A were detected in both patients between attacks. Sequencing revealed a missense mutation in exon 3 in the second extracellular domain of TNFRSF1A, resulting in a substitution of cysteine with arginine at residue 73 (C73R), confirming the diagnosis of TNF receptor-associated periodic syndrome (TRAPS). We were unable to demonstrate a distinct TNFRSF1A shedding defect.

Conclusion: In patients of Nordic descent, affected by dominantly inherited recurrent fever, TRAPS is a diagnosis worthy of attention. All TNFRSF1A mutations hitherto described in the Nordic countries have been different.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • DNA Mutational Analysis
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fever / genetics*
  • Fever / immunology*
  • Finland
  • Humans
  • Mutation, Missense
  • Pedigree
  • Periodicity
  • Polymerase Chain Reaction
  • Receptors, Tumor Necrosis Factor / genetics*
  • Syndrome

Substances

  • Receptors, Tumor Necrosis Factor